TCL Archive NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money. March 18, 2005
TCL Archive ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number June 17, 2011
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification April 10, 1981
